Across TCGA pan-cancer cohorts, GCSIR RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GCSIR’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where GCSIR RNA is repressed in tumor relative to normal tissue. In most cancer types GCSIR is over-expressed in tumor, although a few such as COAD and KICH show the opposite, repressed pattern.
COAD, LUAD, and KICH are the cancer types where GCSIR tumor–normal differential expression is most reproducible.